For Infants With Late-Onset Sepsis, Nafcillin Therapy Is a Safe Alternative to Vancomycin
The Neonatal Antimicrobial Stewardship Program at Nationwide Children’s Hospital in 2014 suggested nafcillin above vancomycin for the empirical treatment of potential late-onset sepsis (LOS) in newborns without a history of methicillin-resistant Staphylococcus aureus colonisation or infection. All 366 infants who received nafcillin or vancomycin for the treatment of potential late-onset sepsis (LOS) at 3 NICUs […]
